Long Road Investment Counsel’s Core Laboratories CLB Stock Holding History

Long Road Investment Counsel’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-8,510	Closed	-$397K	–	66
2019 Q3	$397K	Hold	8,510	–	–	0.23%	64
2019 Q2	$445K	Hold	8,510	–	–	0.26%	61
2019 Q1	$587K	Buy	8,510 +300	+4%	+$20.1K	0.36%	58
2018 Q4	$490K	Hold	8,210	–	–	0.37%	53
2018 Q3	$951K	Sell	8,210 -50	-0.6%	-$5.64K	0.63%	44
2018 Q2	$1.04M	Hold	8,260	–	–	0.74%	43
2018 Q1	$894K	Buy	8,260 +250	+3%	+$27.7K	0.62%	46
2017 Q4	$877K	Hold	8,010	–	–	0.61%	47
2017 Q3	$791K	Hold	8,010	–	–	0.56%	47
2017 Q2	$811K	Hold	8,010	–	–	0.6%	48
2017 Q1	$925K	Hold	8,010	–	–	0.68%	44
2016 Q4	$962K	Hold	8,010	–	–	0.74%	39
2016 Q3	$900K	Hold	8,010	–	–	0.69%	45
2016 Q2	$992K	Hold	8,010	–	–	0.78%	41
2016 Q1	$900K	Hold	8,010	–	–	0.71%	41
2015 Q4	$871K	Hold	8,010	–	–	0.72%	40
2015 Q3	$799K	Hold	8,010	–	–	0.68%	42
2015 Q2	$913K	Hold	8,010	–	–	0.74%	38
2015 Q1	$837K	Hold	8,010	–	–	0.71%	38
2014 Q4	$964K	Buy	+8,010	New	+$1.05M	0.87%	36

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Long Road Investment Counsel's CLB Position: Q4 2019 in Review

Long Road Investment Counsel sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 8,510 shares — an estimated $397K sold.

Long Road Investment Counsel first reported a position in CLB in Q4 2014 and held it in 20 quarters. The position peaked at $1.04M in Q2 2018. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

Long Road Investment Counsel reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
Long Road Investment Counsel sold 8,510 Core Laboratories shares in Q4 2019, an estimated $397K.
Long Road Investment Counsel first reported a position in Core Laboratories in Q4 2014 and held it in 20 quarters.
Long Road Investment Counsel's Core Laboratories position peaked at $1.04M in Q2 2018.
283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Long Road Investment Counsel's 13F filing for Q4 2019, filed 13 Feb 2020.